Transient ischemic attack
Transient cerebral ischemic attacks (TCIA) are sudden, transient, reversible neurological dysfunction caused by focal cerebral ischemia. The attack lasts for several minutes and usually recovers completely within 30 minutes. If it exceeds 2 hours, there will often be mild neurological deficits, or CT and MRI will show signs of brain ischemia. The traditional definition of TCIA is recovery within 24 hours. TCIA is more common in people aged 34 to 65 years old, with 25.3% of people over 65 years old, and more men than women. The onset is sudden, often in the case of changes in body position, excessive activity, sudden rotation or flexion and extension of the neck. There is no precursor to the onset, there are transient neurological localization signs, generally no impaired consciousness, lasting 5 to 20 minutes, and can recur, but generally recover completely within 24 hours without sequelae.
-
Site of disease:
Brain -
Infectious :
Not contagious -
Frequent population:
Middle-aged and elderly people -
Related symptoms:
Hemianopia Multiple elongated and twisted arteries Paralysis Confusion Epilepsy and epileptic seizures -
Concurrent disease:
Related Drugs
PRAVASTATIN SODIUM- pravastatin sodium_tablet
Indication: Pravastatin sodium tablets are indicated: To reduce the risk of myocardial infarction, myocardial revascularization procedures, and cardiovascular mortality in adults with elevated low-density lipoprotein cholesterol (LDL-C) without clinically evident coronary heart disease (CHD). To reduce the risk of coronary death, myocardial infarction, myocardial revascularization procedures, stroke or transient ischemic attack, and slow the progression of coronary atherosclerosis in adults with clinically evident CHD. As an adjunct to diet to reduce LDL-C in adults with primary hyperlipidemia. As an adjunct to diet to reduce LDL-C in pediatric patients ages 8 years and older with heterozygous familial hypercholesterolemia (HeFH). As an adjunct to diet for the treatment of adults with: Primary dysbetalipoproteinemia. Hypertriglyceridemia. Pravastatin sodium is an HMG-CoA reductase inhibitor (statin) indicated ( 1 To reduce the risk of myocardial infarction, myocardial revascularization procedures, and cardiovascular mortality in adults with elevated low-density lipoprotein cholesterol (LDL-C) without clinically evident coronary heart disease (CHD).
Manufacturer:
REMEDYREPACK INC.